References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- ChattopadhyaySMoranRGGoldmanIDPemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applicationsMol Cancer Ther20076240441717308042
- MartinMClinical experience with pemetrexed in breast cancerSemin Oncol2006331 Suppl 2S15S18
- DongXMumperRJNanomedicinal strategies to treat multidrug-resistant tumors: current progressNanomedicine (Lond)20105459761520528455
- GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer200221485811902585
- SchinkelAHJonkerJWMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overviewAdv Drug Deliv Rev200355132912535572
- RavnaAWSylteISagerGA molecular model of a putative substrate releasing conformation of multidrug resistance protein 5 (MRP5)Eur J Med Chem200843112557256718313803
- DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
- LiLShamYYBikadiZElmquistWFpH-Dependent transport of pemetrexed by breast cancer resistance proteinDrug Metab Dispos20113991478148521628496
- UemuraTOguriTOzasaHABCC11/MRP8 confers pemetrexed resistance in lung cancerCancer Sci2010101112404241020718756
- MourskaiaAAAmirEDongZABCC5 supports osteoclast formation and promotes breast cancer metastasis to boneBreast Cancer Res2012146R14923174366
- GaoJFengSSGuoYNanomedicine against multidrug resistance in cancer treatmentNanomedicine (Lond)20127446546822471716
- WickiAWitzigmannDBalasubramanianVHuwylerJNanomedicine in cancer therapy: challenges, opportunities, and clinical applicationsJ Control Release201520013815725545217
- AkbarzadehARezaei-SadabadyRDavaranSLiposome: classification, preparation, and applicationsNanoscale Res Lett20138110223432972
- ClercSBarenholzYLoading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradientsBiochim Biophys Acta1995124022572658541297
- PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNano-carriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
- ZhuYYuFJiaoYReduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5Clin Cancer Res201117227105711521953503
- GreenbergPLLeeSJAdvaniRMitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)J Clin Oncol20042261078108615020609